Chiron Real Estate (XRN) Q4 2025 earnings summary

Executive summary

• Announced a strategic shift to expand from medical office buildings into senior housing and active adult segments, supported by demographic trends and constrained supply.

• Portfolio consists of 189 essential care properties, 96% leased, with $1.5B in real estate and $119M annualized cash NOI as of Q4 2025.

• Leadership changes, including a new CEO and Portfolio Manager, and a formalized strategy have stabilized the balance sheet and driven performance.

• Completed a corporate rebrand and outlined 2026 strategic objectives, including a shift to monthly dividends and participation in major industry conferences.

• Outperformed outpatient medical REIT peers since IPO, but recent higher-rate environment compressed earnings multiples.

Financial highlights

• Nareit defined FFO per share and unit was $0.97 for Q4 2025; Core FFO (AFFO) was $1.16 per share and unit, up 6.4% year-over-year.

• Same-store cash NOI increased 5.4% year-over-year and 2.9% sequentially.

• Net debt to adjusted EBITDA was 6.2x, down from 6.8x in June 2025, with leverage reduced to 44.4% at year-end.

• Transitioning to monthly dividend distributions in April 2026, maintaining the annual $3 per share rate.

• Q4 2025 net loss attributable to common stockholders was $7.4 million ($0.55 per diluted share); full-year net loss was $12.1 million.

Outlook and guidance

• 2026 Core FFO per share and unit guidance range set at $4.30–$4.45, reflecting balance sheet fortification and 1.0–2.0% same store NOI growth.

• Guidance excludes speculative or incremental acquisitions/dispositions beyond those announced as of February 2026.

• Targeting upper quartile earnings growth in the equity REIT universe, aiming for ~6% annual per-share earnings growth.

• 2026 G&A expense expected at $19–$20M; FAD CapEx at $13.5–$14.5M.